Resources

Filter by

June 13, 2024
Blog

The Wild Ride of Medicare Part D Payer Challenges on Expenditures and Concessions

Contracts & Pricing

May 30, 2024
Blog

IRA Part D Redesign, New Gene Therapies Give Hope for Patients, and Updates on the Regeneron Case

Market Access

April 24, 2024
Blog

Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert & the Latest in Sustain Act 340B

Contracts & Pricing

April 4, 2024
Blog

The Top 10 Market Access Challenges

Market Access

March 22, 2024
Blog

FDA Approves Florida Drug Imports from Canada, GLP-1 Market Dilemma, & Illinois Pharma Price Gouging Law Challenged Recap

Contracts & Pricing

February 21, 2024
Blog

Navigating the Complexities of Biopharma/Pharma Net Revenue Forecasting

Gross-to-Net

February 20, 2024
Blog

Navigating the Complexities of Biopharma/Pharma Net Revenue Forecasting

Gross-to-Net

February 1, 2024
Blog

The New Medicare Part D Agreement, AMP Removals Impact on WAC Drug Pricing, and 2023 SPTR Recap

Contracts & Pricing

January 26, 2024
Blog

Transforming Pharmaceutical Trade and Embracing Innovation in Distribution Paradigms

Channel

March 7, 2023
Blog

5 Pharma Gross-to-Net Questions You Should Be Asking

Gross-to-Net

Resources